Cargando…

Interstitial cystitis intravesical therapy

Interstitial cystitis (IC) is a progressive bladder disorder that presents with symptoms of bladder urgency, frequency and pain. The aetiology of the disease remains uncertain, but it is postulated that there is an initial infective insult which damages the glycosaminoglycan (GAG) layer of the bladd...

Descripción completa

Detalles Bibliográficos
Autores principales: Ha, Tanya, Xu, Jie Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522791/
https://www.ncbi.nlm.nih.gov/pubmed/28791236
http://dx.doi.org/10.21037/tau.2017.06.18
_version_ 1783252218412007424
author Ha, Tanya
Xu, Jie Hua
author_facet Ha, Tanya
Xu, Jie Hua
author_sort Ha, Tanya
collection PubMed
description Interstitial cystitis (IC) is a progressive bladder disorder that presents with symptoms of bladder urgency, frequency and pain. The aetiology of the disease remains uncertain, but it is postulated that there is an initial infective insult which damages the glycosaminoglycan (GAG) layer of the bladder urothelium. This defect allows an influx of ions, particularly potassium, which initiates an inflammatory reaction in the bladder wall, which incites the symptoms described above. Treatment initially involves behavioural and oral medication, with second line being intravesical instillation therapy. Treatment strategies focus on restoring lower urinary tract epithelial function, inhibiting neural activation, controlling allergies and relieving symptoms. In this review, current intravesical therapy will be discussed, as well as what lies on the horizon for intravesical therapy in IC.
format Online
Article
Text
id pubmed-5522791
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-55227912017-08-08 Interstitial cystitis intravesical therapy Ha, Tanya Xu, Jie Hua Transl Androl Urol Review Article Interstitial cystitis (IC) is a progressive bladder disorder that presents with symptoms of bladder urgency, frequency and pain. The aetiology of the disease remains uncertain, but it is postulated that there is an initial infective insult which damages the glycosaminoglycan (GAG) layer of the bladder urothelium. This defect allows an influx of ions, particularly potassium, which initiates an inflammatory reaction in the bladder wall, which incites the symptoms described above. Treatment initially involves behavioural and oral medication, with second line being intravesical instillation therapy. Treatment strategies focus on restoring lower urinary tract epithelial function, inhibiting neural activation, controlling allergies and relieving symptoms. In this review, current intravesical therapy will be discussed, as well as what lies on the horizon for intravesical therapy in IC. AME Publishing Company 2017-07 /pmc/articles/PMC5522791/ /pubmed/28791236 http://dx.doi.org/10.21037/tau.2017.06.18 Text en 2017 Translational Andrology and Urology. All rights reserved.
spellingShingle Review Article
Ha, Tanya
Xu, Jie Hua
Interstitial cystitis intravesical therapy
title Interstitial cystitis intravesical therapy
title_full Interstitial cystitis intravesical therapy
title_fullStr Interstitial cystitis intravesical therapy
title_full_unstemmed Interstitial cystitis intravesical therapy
title_short Interstitial cystitis intravesical therapy
title_sort interstitial cystitis intravesical therapy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5522791/
https://www.ncbi.nlm.nih.gov/pubmed/28791236
http://dx.doi.org/10.21037/tau.2017.06.18
work_keys_str_mv AT hatanya interstitialcystitisintravesicaltherapy
AT xujiehua interstitialcystitisintravesicaltherapy